![]() |
| Julie Adrian |
Finn Partners has named Julie Adrian managing partner and UK health group lead, a newly created post, as the independent firm strengthens its global healthcare capabilities.
Adrian, who has more than 25 years of experience, worked as global chief experience officer at Real Chemistry, president Europe communications at Syneos Health, president Europe communications at Inventiv Health, and managing director at Chandler Chicco Agency.
She joins Finn Partners from Alverium Health, where Adrian was CEO & co-founder.
The addition of Adrian bolsters the UK health unit's effort to build a comprehensive suite of services including PR, IR, patient advocacy, digital marketing, scientific & medical communications support, and thought leadership.
Adrian reports to Gil Bashe, chair of global health & purpose. She will work closely with Fern Lazar, managing partner & global health practice lead, and Chantal Bowman-Boyles, managing parter of the EMEA region.
Bashe called Adrian’s appointment a pivotal moment for the firm. “Her energy, experience, and dedication to client success make her an invaluable asset and an addition to our team that will signal to clients that we never rest on our laurels and continue to pursue excellence in service to their goals,” he said.
Finn Partners ranks as O’Dwyer’s No. 8 healthcare firm with 2023 fees of $52M.


Healing the Sick Care System: Why People Matter, a new book from FINN Partners chair global health and purpose Gil Bashe, says that the current healthcare system is not broken because it lacks innovation, talent or investment, but because it has lost sight of the people it exists to serve.
Jeff Smokler, former president at healthcare specialist imre, joins Washington-based Avoq to head its PA practice.
Supreme Group, healthcare marketing and communications platform, has merged its Amendola Communications (Fountain Hills, AZ) and Health+Commerce (Newport Beach, CA) units to form Supreme Communications, a full-service PR shop, under Ketchum alum Nicky Battle.
Even as technology changes the rules of engagement, digital health brands still control the most powerful tool they have—their story.



